期刊文献+

宫颈癌发病情况及细胞DNA定量分析技术应用于宫颈癌筛查的临床研究 被引量:15

原文传递
导出
摘要 目的采用常规细胞学检查和细胞DNA定量分析技术进行宫颈癌筛查,以组织学诊断为金标准,评估细胞DNA定量分析诊断技术在筛查宫颈癌中应用的敏感性、特异性和准确性。方法制片采用液基滴片技术,每个标本制成两张薄层细胞学标本片,其中一张进行巴氏染色做常规细胞学诊断,另外一张进行Feulgen染色做细胞DNA定量测定。结果 4000例中3820例DNA倍体检测阴性,通过细胞DNA定量分析方法在筛查发现宫颈病变的敏感性为81%,宫颈病变特异性为72%,而常规细胞学方法为51%和90%。结论对同一个标本采用不同的筛查方法进行评估,比较常规细胞学与细胞DNA定量分析技术在宫颈癌筛查中的应用成效。DNA检测也可以作为一个质控方法核实常规细胞学的结果,保证细胞学诊断的准确性。
出处 《临床医学》 CAS 2014年第6期94-96,共3页 Clinical Medicine
  • 相关文献

参考文献6

二级参考文献32

  • 1金力,郎景和,王友芳,程雪梅.高危人类乳头状病毒负荷与宫颈上皮内瘤变的分级关系[J].生殖与避孕,2006,26(7):422-425. 被引量:39
  • 2李立明.流行病学[M].北京:人民卫生出版社,2007.454.
  • 3Schiffman M,Herrero R,Hildesheim A,et al.HPV DNA testing in cervical cancer screening:results from women in a high risk province of Costa Riba[J].JAMA,2000,283(1):87-93.
  • 4Eileen M,Burd.Human papillomavirus and cervical cancer[J].Clin Miero Rev,2003,16:19.
  • 5Lazcano-Ponce E,Herrero R,Munoz N,et al.Epidemiology of HPV infection among maxican women with normal cervical cytology[J].Int J Cancer,2001,91(3):412-420.
  • 6John W,Tina L,Janusz A,et al.Prevalence of infection with carcinogenic human papillomavirus among older women[J].CMAJ,2002,167(8):871-873.
  • 7Zur Hausen H. Papillomaviruses in human cancer[J]. Cancer, 1987, 59 : 1692.
  • 8Tavassoli FA, Devilee P. World Health Organization classication of tumors pathology and genetics, tumors of the breast and femal genital organs [M]. Lyon: IARC Press, 2003 : 262 - 272.
  • 9Petry KU, Menton S, Menton Met al. Inclusion of I-tPV lesting in rou- tine cervical cancer screening for woman above 29 years in Germany: results for 8 466 patients [J].Br J Cancer, 2003, 88 (10) : 1570.
  • 10Bratti MC, Rodriguez AC, Schiffman M et al. Description of a sevenyear prospective study of human papil|omavirus infection and cervical neoplasia among 10 000 women in Guanacaste, Costa Rica[J].Rev Panam Salud Publica, 2004, 15 (2) : 75.

共引文献132

同被引文献89

  • 1李永红,毕晓芳,李晶.细胞DNA倍体分析法对宫颈病变的临床诊断价值[J].宁夏医科大学学报,2013,35(7):821-823. 被引量:3
  • 2卢建军,张林燕.紫杉醇与顺铂联合化疗治疗宫颈癌的疗效及与组织微血管和微淋巴管密度的关系[J].中国生化药物杂志,2014,34(5):92-94. 被引量:10
  • 3孙小蓉,李玉兰,车东媛,晏想成,凌慧芳,凃洪章,汪键.用细胞DNA定量分析方法进行宫颈癌普查的临床研究[J].诊断病理学杂志,2005,12(1):12-16. 被引量:67
  • 4邝红芳,巫雪珍,魏永聪,等.液基薄层细胞学筛查宫颈癌的应用价值[J].现代医院,2010,10(z1):60-61.
  • 5蔡小娟,李梅娟.高危型人乳头瘤病毒检测与液基细胞学检查在宫颈癌筛查中的联合应用价值[J].现代医院,2010,10(z2):81—82.
  • 6Bakhidze EV, Lavrinovich OE, of human papilloma virus DNA squamous cell cervical cancer] 233-237. Chepik OF, et al. [ Prognostic value test in patients surgically treated for [J]. Vopr Onkol, 2012, 58(2):.
  • 7Rizvi MA, Zaki M, Afzal M, et al. Nuclear blebbing of biologically active organoselenium compound towards human cervical cancer cell (HeLa): In vitro DNA/HSA binding, cleavage and cell imaging studies[ J~. Eur J Med Chem, 2014, 90( 1 ) : 876-888.
  • 8Peirson L, Fitzpatrick- Lewis D, Ciliska D, et al. Screening for cervical cancer: a systematic review and meta-analysis [ J ]. Syst Rev, 2013,2 ( 1 ) : 35.
  • 9Randel A. ACOG releases guidelines on cervical cancer screening [J]. Am Fam Physician, 2013,88 ( 11 ) : 776- 777.
  • 10Paesi S, Correa L, Tregnago MC, et al. Human papil- lomavirus among women with atypicai squamous cells of undetermined significance in southern Brazil [ J ]. Int J Gynaecol Obstet, 2015,128(1) :23-26.

引证文献15

二级引证文献53

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部